Innovating Works

RUBYNANOMED LDA

BRIGHT: Best-in-class canceR dIaGnostic cHip for patient sTratification. RUBYNANOMED LDA tramitó un HORIZON EUROPE: HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 Through advanced microengineering and nanotechnology, we have developed a proprietary microfluidic-based liquid biopsy device, the RUBYchip™...
2022-07-08 - 2025-04-30 | Financiado
BIOCELLPHE: Ultrasensitive BIOsensing platform for multiplex CELLular protein PHEnotyping at single cell level RUBYNANOMED LDA participó en un H2020: H2020-FETOPEN-2018-2020 BIOCELLPHE provides frontier scientific and technological advancements to generate a breakthrough technology realizing the identification of...
2021-01-20 - 2025-03-31 | Financiado
PERSIST: Patients centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial In... RUBYNANOMED LDA participó en un H2020: H2020-SC1-DTH-2018-2020 PERSIST aims at developing an open and interoperable ecosystem to improve the care of cancer survivors. The key results to be achieved by pa...
2019-11-05 - 2023-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.